SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer

Publication date: 15 July 2021Source: Life Sciences, Volume 277Author(s): Surya Kant Tripathi, Bijesh Kumar Biswal
Source: Life Sciences - Category: Biology Source Type: research